| abstract |
The invention relates to a pharmaceutical formulation in the form of agglomerates containing A) an adjuvant consisting of a) 60 - 97 % by weight of sugar or sugar alcohols, b) 1 - 25 % by weight of a disintegration agent c)1 - 15 % by weight of water insoluble, film-forming polymers d) 0 -15 % by weight of water soluble polymers, and e) 0 - 15 % by weight of additional conventional pharmaceutical adjuvants, the sum of the components a) to e) totalling 100 % by weight, and B) at least one active ingredient. |